entertainment -WSS

entertainment

author：leisure time 2025-09-27 09:46:51 - browse：2

STAT@ASCO 2024 — Chris Boshoff, far right, speaking at a panel with, from left, Matthew Herper of STAT, Ken Keller, Levi Garraway, and Susan Galbraith. Megan Bearder Photography

CHICAGO — The ways clinicians can treat cancers effectively are expanding, partly because technologies today are making old ideas possible, said a panel of oncology industry leaders at STAT@ASCO, STAT’s event here at the annual American Society of Clinical Oncology meeting.

“We’re seeing this expansion in modalities. We have more types of modalities that have arrived or arriving that allow us to exploit targets we’ve known about more than ever before. It’s very exciting,” said Levi Garraway, the chief medical officer of Genentech, at the event. “Things we’ve known about for a long time can be drugged for the first time or in a new, different way.”

That’s led to a surge of new medicines ranging from small molecules to cell therapies, with the potential uses of these treatments expanding into earlier lines of therapy and more cancer types each year. One example the panel singled out is the drug Enhertu, which recently received a tumor-agnostic approval from the Food and Drug Administration.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Some medical students still think black patients feel less pain

entertainment

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Grad students accuse University of California of wage theft

FDA weighs limits of animal data in assessing artificial wombs

Free Covid tests will again be offered to all U.S. households

Bird flu makes raw milk dangerous to consume, mouse study finds

Lawsuit challenges CMS nursing home minimum staffing rule

entertainment

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

focus

Tori Bowie and the unacceptable rates of Black maternal death

Why the drug industry's warnings on the IRA's impact fall short

FDA approval of Sarepta Duchenne genetic therapy gives me hope

What happened to the House vote on health price transparency?

Bright Health sells Medicare Advantage business to Molina

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Trump demands the U.S. pay no more for drugs than other countries … again

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Drug repurposing or repositioning? The language matters

Free Covid tests will again be offered to all U.S. households

focus

Transgender sports debate: Physicians say bans are health issue

The Bio Revolution is changing business and society

Midwives could help bridge maternal health disparities in the U.S.

Medical students need to learn the potent medicine of empathy

New research sheds light on how often breast cancer is overdiagnosed

Should insurance cover cosmetic surgery?

Wikipedia

entertainment

hotspot

hotspot